Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2021-09-28 00:00:00 ET · period of report 2021-09-24 · accession 0001453687-21-000121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-28 | 2021-09-24 | RNAC | TRABER PETER G | Chief Medical Off | A - Grant | $0.00 | +9,100 | 144.6K | +7% | $0 |
| D | 2021-09-28 | 2021-09-24 | RNAC | TRABER PETER G | Chief Medical Off | A - Grant | $0.00 | +54.4K | 54.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-24 | A | A | 9,100 | $0.00 | 144,600 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2021-09-24 | A | A | 54,400 | $0.00 | 54,400 | D | $4.32 · — to 2031-09-23 | 54,400 Common Stock | (F2) This option vests as to 25% on September 24, 2022. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter. |